Lv2
180 积分 2024-09-05 加入
Deruxtecan-Induced Reversible Fanconi Syndrome
1天前
已关闭
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
1天前
已完结
Toxicity profiles of antibody-drug conjugates for anticancer treatment: a systematic review and meta-analysis
4天前
已关闭
Antibody–drug conjugates: a practical review on clinical management of toxicities
4天前
已完结
Risk Factors for Immune Checkpoint Inhibitor-Related Pneumonitis in Cancer Patients: A Systemic Review and Meta-Analysis
13天前
已关闭
Risk of Ophthalmotoxicity Associated with Antibody-Drug Conjugates: A Systematic Review and Meta-analysis
13天前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
24天前
已完结
Sacituzumab tirumotecan (SKB264/MK-2870) in patients (pts) with previously treated locally recurrent or metastatic triple-negative breast cancer (TNBC): Results from the phase III OptiTROP-Breast01 study
24天前
已完结
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin
1个月前
已关闭
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial
1个月前
已关闭
皖公网安备34019202002308
